Compound Q&A
What is the market or research trend for Dehydro silodosin (CAS: 175870-21-0)?
Answer
The market for Dehydro silodosin (CAS: 175870-21-0) is primarily driven by its use in treating benign prostatic hyperplasia. Research trends focus on evaluating its efficacy and safety compared to other alpha-blockers. There is also ongoing interest in its potential for treating other urological conditions. Market trends suggest growing demand, but with increasing scrutiny on drug efficacy and safety.
About
CAS No
175870-21-0
English Name
Dehydro silodosin
Molecular Formula
C25H30F3N3O4
Molecular Weight
493.53 g/mol
SMILES
CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=CC=CC=C3OCC(F)(F)F
InChIKey
VICSLOHTZDWOFF-QGZVFWFLSA-N
Last Updated: 2026-03-03 01:43
